Retia Medical

Founded in 2012 in the United States, Retia Medical LLC specializes in hemodynamic monitoring solutions.Retia Medical Systems, Inc. specializes in advanced hemodynamic monitoring solutions, primarily through its flagship product, the Argos® Cardiac Output Monitor. This device utilizes the proprietary Multi-Beat Analysis (MBA™) algorithm to provide consistently accurate hemodynamic data, which is crucial for guiding medical interventions in critical care settings. The Argos Monitor is designed to optimize perfusion and oxygen delivery for high-risk patients across various clinical environments, including operating rooms, intensive care units, and emergency departments. The technology serves a diverse client base, including hospitals and healthcare institutions that manage patients with conditions such as sepsis, trauma, and cardiac complications.S.Retia Medical Systems generates revenue through direct sales of the Argos® Cardiac Output Monitor to healthcare providers, alongside potential service agreements and client training programs. The business model aligns closely with B2B transactions, where healthcare institutions purchase the monitoring systems for use in critical care settings. The transaction structure includes one-time equipment sales along with ongoing support and training, facilitating the integration of the Argos Monitor into clinical workflows. While specific pricing plans for the Argos Monitor are not disclosed, it is expected that these offerings cater to the financial frameworks typical in healthcare procurement, including capital expenditure for medical devices. Retia Medical aims to enhance its product offerings while exploring potential expansion into additional geographic markets, focusing on increasing its presence in North America and potentially entering international markets by 2024.

1. Series B

   Jul 18, 2022

   Amount

   $10M

   Investors

   Locked